Company / SG&A Expense
Microbot Medical Inc. SG&A Expense History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$8.8M
FY2015
5-year range
$7.4M / $9.5M
FY2011-FY2015
Trend
+20.0%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense returned to growth in FY2015 after 3 years of decline, reaching $9M.
Based on SEC 10-K filings.
$9M in FY2015 with a 3-year CAGR of -2.0%.
Increased from $8M to $9M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -2.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -2.0%, indicating a declining trend.
- In FY2015, sg&a expense increased 20.0% year-over-year.
- Peak sg&a expense was recorded in FY2011.
- Lowest sg&a expense in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -2.00 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | $8.8M | +20.0% |
| FY2014 | $7.4M | -10.3% |
| FY2013 | $8.2M | -12.5% |
| FY2012 | $9.4M | -1.6% |
| FY2011 | $9.5M | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026